TherapeuticsMD (TXMD) Competitors $1.15 +0.07 (+6.48%) As of 01/24/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TXMD vs. IVVD, NRXP, ICCC, ACHL, ALRN, NBRV, KZR, VTVT, DYAI, and TNXPShould you be buying TherapeuticsMD stock or one of its competitors? The main competitors of TherapeuticsMD include Invivyd (IVVD), NRx Pharmaceuticals (NRXP), ImmuCell (ICCC), Achilles Therapeutics (ACHL), Aileron Therapeutics (ALRN), Nabriva Therapeutics (NBRV), Kezar Life Sciences (KZR), vTv Therapeutics (VTVT), Dyadic International (DYAI), and Tonix Pharmaceuticals (TNXP). These companies are all part of the "pharmaceutical products" industry. TherapeuticsMD vs. Invivyd NRx Pharmaceuticals ImmuCell Achilles Therapeutics Aileron Therapeutics Nabriva Therapeutics Kezar Life Sciences vTv Therapeutics Dyadic International Tonix Pharmaceuticals TherapeuticsMD (NASDAQ:TXMD) and Invivyd (NASDAQ:IVVD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, community ranking, dividends and institutional ownership. Which has better earnings & valuation, TXMD or IVVD? TherapeuticsMD has higher revenue and earnings than Invivyd. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTherapeuticsMD$1.60M8.31-$10.28MN/AN/AInvivydN/AN/A-$198.64M-$1.96-0.24 Which has more volatility and risk, TXMD or IVVD? TherapeuticsMD has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Comparatively, Invivyd has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Do analysts prefer TXMD or IVVD? Invivyd has a consensus price target of $7.89, indicating a potential upside of 1,567.55%. Given Invivyd's stronger consensus rating and higher probable upside, analysts plainly believe Invivyd is more favorable than TherapeuticsMD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TherapeuticsMD 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Invivyd 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Does the MarketBeat Community believe in TXMD or IVVD? TherapeuticsMD received 370 more outperform votes than Invivyd when rated by MarketBeat users. However, 80.00% of users gave Invivyd an outperform vote while only 58.57% of users gave TherapeuticsMD an outperform vote. CompanyUnderperformOutperformTherapeuticsMDOutperform Votes38658.57% Underperform Votes27341.43% InvivydOutperform Votes1680.00% Underperform Votes420.00% Do institutionals and insiders hold more shares of TXMD or IVVD? 30.7% of TherapeuticsMD shares are held by institutional investors. Comparatively, 70.4% of Invivyd shares are held by institutional investors. 2.3% of TherapeuticsMD shares are held by company insiders. Comparatively, 17.9% of Invivyd shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor TXMD or IVVD? In the previous week, Invivyd had 1 more articles in the media than TherapeuticsMD. MarketBeat recorded 1 mentions for Invivyd and 0 mentions for TherapeuticsMD. TherapeuticsMD's average media sentiment score of 0.00 beat Invivyd's score of -1.00 indicating that TherapeuticsMD is being referred to more favorably in the media. Company Overall Sentiment TherapeuticsMD Neutral Invivyd Negative Is TXMD or IVVD more profitable? Invivyd has a net margin of 0.00% compared to TherapeuticsMD's net margin of -207.77%. TherapeuticsMD's return on equity of -14.08% beat Invivyd's return on equity.Company Net Margins Return on Equity Return on Assets TherapeuticsMD-207.77% -14.08% -9.61% Invivyd N/A -155.33%-114.88% SummaryInvivyd beats TherapeuticsMD on 9 of the 16 factors compared between the two stocks. Get TherapeuticsMD News Delivered to You Automatically Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TXMD vs. The Competition Export to ExcelMetricTherapeuticsMDPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.26M$6.59B$5.43B$9.28BDividend YieldN/A2.95%5.37%3.97%P/E RatioN/A9.8988.9317.53Price / Sales8.31329.861,235.73136.58Price / CashN/A65.0944.3737.67Price / Book0.425.245.084.74Net Income-$10.28M$154.63M$117.95M$224.52M7 Day Performance8.49%4.57%3.12%1.43%1 Month Performance5.50%0.11%2.65%1.62%1 Year Performance-49.34%9.47%30.21%21.55% TherapeuticsMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TXMDTherapeuticsMD0.5644 of 5 stars$1.15+6.5%N/A-50.0%$13.26M$1.60M0.00420IVVDInvivyd2.9393 of 5 stars$0.41-7.5%$7.89+1,840.8%-89.3%$48.61MN/A-0.21100Negative NewsGap UpNRXPNRx Pharmaceuticals2.4702 of 5 stars$4.01-5.9%$31.67+689.7%-92.3%$48.48MN/A-1.872Gap UpICCCImmuCellN/A$5.26+0.6%N/A-2.1%$46.88M$23.84M-10.5270Gap DownACHLAchilles Therapeutics2.1148 of 5 stars$1.14-0.9%$4.00+250.9%+22.2%$46.85MN/A-0.69250ALRNAileron Therapeutics2.8018 of 5 starsN/A$19.00+∞N/A$45.72MN/A0.009NBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M-0.0770Analyst ForecastKZRKezar Life Sciences3.0198 of 5 stars$6.19-2.4%$39.50+538.1%-22.8%$45.19M$7M-0.4760High Trading VolumeVTVTvTv Therapeutics1.5663 of 5 stars$14.05flat$35.00+149.1%+77.8%$44.82M$2.02M-3.109Gap UpDYAIDyadic International2.4684 of 5 stars$1.50+0.7%$6.00+300.0%+1.4%$44.38M$3.36M-6.527Positive NewsGap UpTNXPTonix Pharmaceuticals3.2757 of 5 stars$0.24+0.2%$53.50+22,617.6%-96.1%$44.01M$7.77M0.0050Analyst ForecastNews CoverageGap Up Related Companies and Tools Related Companies Invivyd Alternatives NRx Pharmaceuticals Alternatives ImmuCell Alternatives Achilles Therapeutics Alternatives Aileron Therapeutics Alternatives Nabriva Therapeutics Alternatives Kezar Life Sciences Alternatives vTv Therapeutics Alternatives Dyadic International Alternatives Tonix Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TXMD) was last updated on 1/26/2025 by MarketBeat.com Staff From Our PartnersNEW A.I. giant trading up to 84% less than MSFT – set to soar in 2025?I’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TherapeuticsMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TXMD Stock Alerts